BACKGROUND: TRB3, a human homolog of Drosophila Tribbles, has been shown as a critical negative regulator of Akt (also known as protein kinase B), which is a key component in insulin signaling. In addition, TRB3 is another PPAR-target gene and functions as an important link between glucose and lipid metabolism. The Q84R polymorphic variant of TRB3 has been linked to insulin resistance and related clinical outcomes. However, it is unclear whether this polymorphism is associated with type 2 diabetes mellitus (T2DM) in the Chinese population. METHODS: In this study, we genotyped Q84R polymorphism in 177 patients with T2DM and 245 control subjects in Chinese population by using the polymerase chain reaction/ligase detection reaction (PCR/LDR) assay. RESULTS: No significant difference in the Q84R genotype frequency was observed between T2DM patients and controls (P = 0.642). In T2DM group, the Q84R variant in cases was associated with higher FINS, higher HOMA-IR, and lower LnISI (P = 0.003, 0.001, and 0.001, respectively). However, the changes in HOMA-IR and LnISI were not significant in controls (the P value is 0.098 and 0.203, respectively). In addition, FINS levels were also significantly increased from Q84Q to R84 in controls (P = 0.036). CONCLUSION: Our data indicate that the TRB3 Q84R polymorphism is not associated with T2DM in Chinese population. However, the Q84R variant is associated with insulin resistance among T2DM patients in Chinese population.
BACKGROUND:TRB3, a human homolog of DrosophilaTribbles, has been shown as a critical negative regulator of Akt (also known as protein kinase B), which is a key component in insulin signaling. In addition, TRB3 is another PPAR-target gene and functions as an important link between glucose and lipid metabolism. The Q84R polymorphic variant of TRB3 has been linked to insulin resistance and related clinical outcomes. However, it is unclear whether this polymorphism is associated with type 2 diabetes mellitus (T2DM) in the Chinese population. METHODS: In this study, we genotyped Q84R polymorphism in 177 patients with T2DM and 245 control subjects in Chinese population by using the polymerase chain reaction/ligase detection reaction (PCR/LDR) assay. RESULTS: No significant difference in the Q84R genotype frequency was observed between T2DM patients and controls (P = 0.642). In T2DM group, the Q84R variant in cases was associated with higher FINS, higher HOMA-IR, and lower LnISI (P = 0.003, 0.001, and 0.001, respectively). However, the changes in HOMA-IR and LnISI were not significant in controls (the P value is 0.098 and 0.203, respectively). In addition, FINS levels were also significantly increased from Q84Q to R84 in controls (P = 0.036). CONCLUSION: Our data indicate that the TRB3Q84R polymorphism is not associated with T2DM in Chinese population. However, the Q84R variant is associated with insulin resistance among T2DM patients in Chinese population.
Authors: H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum Journal: Science Date: 2001-06-01 Impact factor: 47.728
Authors: Seung-Hoi Koo; Hiroaki Satoh; Stephan Herzig; Chih-Hao Lee; Susan Hedrick; Rohit Kulkarni; Ronald M Evans; Jerrold Olefsky; Marc Montminy Journal: Nat Med Date: 2004-04-25 Impact factor: 53.440
Authors: S Ghosh; R M Watanabe; T T Valle; E R Hauser; V L Magnuson; C D Langefeld; D S Ally; K L Mohlke; K Silander; K Kohtamäki; P Chines; J Balow; G Birznieks; J Chang; W Eldridge; M R Erdos; Z E Karanjawala; J I Knapp; K Kudelko; C Martin; A Morales-Mena; A Musick; T Musick; C Pfahl; R Porter; J B Rayman Journal: Am J Hum Genet Date: 2000-10-13 Impact factor: 11.043
Authors: Jiarong Liu; Xuxia Wu; John L Franklin; Joseph L Messina; Helliner S Hill; Douglas R Moellering; R Grace Walton; Mitchell Martin; W Timothy Garvey Journal: Am J Physiol Endocrinol Metab Date: 2009-12-08 Impact factor: 4.310
Authors: D Weismann; D M Erion; I Ignatova-Todorava; Y Nagai; R Stark; J J Hsiao; C Flannery; A L Birkenfeld; T May; M Kahn; D Zhang; X X Yu; S F Murray; S Bhanot; B P Monia; G W Cline; G I Shulman; V T Samuel Journal: Diabetologia Date: 2010-12-29 Impact factor: 10.122
Authors: Joel Armstrong; Mark Diekhans; Stefanie Nachtweide; Ian T Fiddes; Zev N Kronenberg; Jason G Underwood; David Gordon; Dent Earl; Thomas Keane; Evan E Eichler; David Haussler; Mario Stanke; Benedict Paten Journal: Genome Res Date: 2018-06-08 Impact factor: 9.438
Authors: Zachary Fischer; Rahul Das; Anna Shipman; Jin-Yuan Fan; Laramie Pence; Samuel Bouyain; Leonard L Dobens Journal: Dis Model Mech Date: 2017-12-19 Impact factor: 5.758